| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 213.72B | 226.46B | 223.61B | 223.97B | 104.03B | 114.25B |
| Gross Profit | 100.19B | 120.62B | 101.39B | 55.09B | 23.61B | 22.65B |
| EBITDA | 18.09B | 34.54B | 24.37B | -48.34B | 14.34B | 52.44B |
| Net Income | 19.27B | 25.71B | 20.52B | -49.91B | 8.72B | 35.00B |
Balance Sheet | ||||||
| Total Assets | 7.88T | 8.60T | 7.76T | 7.60T | 7.18T | 6.73T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 2.02T | 1.41T | 1.58T | 1.28T | 1.14T |
| Total Debt | 1.25T | 1.31T | 855.94B | 1.04T | 683.39B | 1.04T |
| Total Liabilities | 7.41T | 8.11T | 7.30T | 7.21T | 6.75T | 6.24T |
| Stockholders Equity | 459.56B | 479.94B | 451.42B | 384.40B | 438.66B | 493.49B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 116.15B | -62.98B | 0.00 | -67.37B | 248.33B |
| Operating Cash Flow | 0.00 | 118.46B | -56.90B | 0.00 | -61.38B | 253.90B |
| Investing Cash Flow | 0.00 | -497.40B | -147.85B | 167.44B | 213.94B | -23.83B |
| Financing Cash Flow | 0.00 | 486.96B | 46.59B | 281.15B | -18.07B | -16.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥483.33B | 16.33 | 3.95% | 2.19% | 16.41% | 51.17% | |
72 Outperform | ¥394.96B | 10.68 | 8.52% | 2.12% | 11.88% | 85.95% | |
72 Outperform | ¥357.65B | 13.64 | ― | 3.01% | 25.56% | 26.08% | |
71 Outperform | ¥374.76B | 12.86 | ― | 2.94% | 14.34% | 213.31% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥460.26B | 20.42 | ― | 1.50% | 18.76% | 15.43% | |
56 Neutral | ¥369.39B | 14.16 | 4.74% | 3.38% | 4.61% | 17.29% |